VIR
Vir Biotechnology, Inc.
Vir Biotechnology, Inc. (VIR) has 15 SEC Form 4 filings (18 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Jun 10, 2026.
Insiders have net sold $1.2M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Marianne De Backer
- Employees:408
- HQ:San Francisco, CA, US
- IPO:2019-10-11
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.2M
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Market Cap
$1.5B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| SVP, Chief Accounting Officer | Sale | 379 | $4K | Jun 2 | SEC ↗ | |
Napolitano JanetFirst filing | Director | Sale | 3,200 | $30K | Jun 2 | SEC ↗ |
| Director | Sale | 22,000 | $221K | May 4 | SEC ↗ | |
De Backer MarianneFirst filing | President and CEO | Sale | 72,559 | $664K | Apr 7 | SEC ↗ |
SATO VICKI LFirst filing | Director | Sale | 22,000 | $200K | Apr 2 | SEC ↗ |
Sabatini BrentFirst filing | SVP, Chief Accounting Officer | Sale | 7,711 | $70K | Mar 24 | SEC ↗ |
Related companies
Vir Biotechnology, Inc. is in the Healthcare sector.